In CLL, the NF-kB signaling pathway may be deregulated by mutations affecting the BIRC3 gene, which encodes for a component of the TRAF3/MAP3K14-TRAF2/BIRC3-negative regulatory complex of non-canonical NF-κB signaling [9]. Here, TRAF2 is linked to B-cell chronic lymphocytic leukemia.